🇺🇸 FDA
Patent

US 10000456

Polycyclic compounds as lysophosphatidic acid receptor antagonists

granted A61PA61P1/00A61P1/16

Quick answer

US patent 10000456 (Polycyclic compounds as lysophosphatidic acid receptor antagonists) held by AMIRA PHARMACEUTICALS, INC. expires Mon Jun 14 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
AMIRA PHARMACEUTICALS, INC.
Grant date
Tue Jun 19 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 14 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61P, A61P1/00, A61P1/16, A61P11/00, A61P11/06